Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Weers

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Vox Sanguinis|August 15, 1998
Perfluorocarbon compoundsN S Faithfull, J G Weers
Biochemistry|May 20, 1986
Triplet-singlet energy transfer in the complex of auramine O with horse liver alcohol dehydrogenaseJ G Weers, A H Maki
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Fluorocarbon emulsions--the stability issueM Postel, J G Riess, J G Weers
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Analysis of Ostwald ripening in fluorocarbon emulsions by sedimentation field-flow fractionationR A Arlauskas, D H Klein, J G Weers
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Stabilization of perflubron emulsions with egg yolk phospholipidT J Pelura, C S Johnson, T E Tarara, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Room temperature stable perfluorocarbon emulsions with acceptable half-lives in the reticuloendothelial systemJ G Weers, J Liu, T Fields, et al.
Pharmaceutical Research|May 9, 2000
Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tractA I Bot, T E Tarara, D J Smith, et al.
Pharmaceutical Research|April 6, 2000
Hollow porous particles in metered dose inhalersL A Dellamary, T E Tarara, D J Smith, et al.
Pharmaceutical Research|August 11, 2001
Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccineA I Bot, D J Smith, S Bot, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Influence of perflubron emulsion particle size on blood half-life and febrile response in ratsP E Keipert, S Otto, S F Flaim, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vox Sanguinis|August 15, 1998
Perfluorocarbon compoundsN S Faithfull, J G Weers
Biochemistry|May 20, 1986
Triplet-singlet energy transfer in the complex of auramine O with horse liver alcohol dehydrogenaseJ G Weers, A H Maki
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Fluorocarbon emulsions--the stability issueM Postel, J G Riess, J G Weers
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Analysis of Ostwald ripening in fluorocarbon emulsions by sedimentation field-flow fractionationR A Arlauskas, D H Klein, J G Weers
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Stabilization of perflubron emulsions with egg yolk phospholipidT J Pelura, C S Johnson, T E Tarara, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Room temperature stable perfluorocarbon emulsions with acceptable half-lives in the reticuloendothelial systemJ G Weers, J Liu, T Fields, et al.
Pharmaceutical Research|May 9, 2000
Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tractA I Bot, T E Tarara, D J Smith, et al.
Pharmaceutical Research|April 6, 2000
Hollow porous particles in metered dose inhalersL A Dellamary, T E Tarara, D J Smith, et al.
Pharmaceutical Research|August 11, 2001
Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccineA I Bot, D J Smith, S Bot, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Influence of perflubron emulsion particle size on blood half-life and febrile response in ratsP E Keipert, S Otto, S F Flaim, et al.
Pageof 1